Article ; Online: [Anti-hepatitis C Virus Strategy Targeting the Entry Steps].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
2018 Volume 139, Issue 1, Page(s) 89–95
Abstract: Hepatitis C virus (HCV) infection is a major leading cause of chronic severe liver diseases such as cirrhosis and hepatocellular carcinoma. The recent direct-acting antivirals (DAAs) for the treatment of HCV infection offer very high cure rates, but DAAs ...
Abstract | Hepatitis C virus (HCV) infection is a major leading cause of chronic severe liver diseases such as cirrhosis and hepatocellular carcinoma. The recent direct-acting antivirals (DAAs) for the treatment of HCV infection offer very high cure rates, but DAAs are vulnerable to drug resistance because HCV is an RNA virus, which generally has very high mutation rates. DAA resistance-associated variants of HCV could reduce the effectiveness of DAAs in the future. Thus, the continuous development of new anti-HCV drugs against different target molecules is needed. We have been studying the host factors involved in HCV entry into cells. From those studies, we obtained novel candidates for host-targeting anti-HCV entry inhibitors, such as monoclonal antibodies against HCV receptors, which can be used together with DAAs. In this symposium review, we present and discuss our recent work on anti-HCV strategies targeting HCV entry steps. |
---|---|
MeSH term(s) | Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal/therapeutic use ; Antiviral Agents ; Claudin-1/antagonists & inhibitors ; Drug Discovery ; Drug Resistance, Viral ; Hepacivirus/drug effects ; Hepacivirus/pathogenicity ; Hepatitis C/drug therapy ; Hepatitis C/virology ; Humans ; Mice ; Molecular Targeted Therapy ; Occludin/antagonists & inhibitors ; Receptors, Virus/immunology |
Chemical Substances | Antibodies, Monoclonal ; Antiviral Agents ; Claudin-1 ; Occludin ; Receptors, Virus |
Language | Japanese |
Publishing date | 2018-12-31 |
Publishing country | Japan |
Document type | Journal Article ; Review |
ZDB-ID | 200514-1 |
ISSN | 1347-5231 ; 0031-6903 ; 0372-7750 ; 0919-2085 ; 0919-2131 |
ISSN (online) | 1347-5231 |
ISSN | 0031-6903 ; 0372-7750 ; 0919-2085 ; 0919-2131 |
DOI | 10.1248/yakushi.18-00164-5 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 643: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.